Conmed Corp (CNMD)
61.92
-8.09
(-11.56%)
USD |
NYSE |
Apr 25, 16:00
61.92
0.00 (0.00%)
After-Hours: 16:55
Conmed Cash from Financing (Quarterly): -58.77M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -58.77M |
| September 30, 2023 | -37.23M |
| June 30, 2023 | -19.79M |
| March 31, 2023 | 5.35M |
| December 31, 2022 | 11.52M |
| September 30, 2022 | 46.88M |
| June 30, 2022 | 159.12M |
| March 31, 2022 | 7.489M |
| December 31, 2021 | -40.79M |
| September 30, 2021 | -29.79M |
| June 30, 2021 | -22.10M |
| March 31, 2021 | -8.872M |
| December 31, 2020 | -27.16M |
| September 30, 2020 | -35.66M |
| June 30, 2020 | 8.031M |
| March 31, 2020 | 2.739M |
| December 31, 2019 | -36.97M |
| September 30, 2019 | -23.42M |
| June 30, 2019 | -17.68M |
| March 31, 2019 | 378.95M |
| December 31, 2018 | -31.64M |
| September 30, 2018 | 6.457M |
| June 30, 2018 | -13.78M |
| March 31, 2018 | -33.30M |
| December 31, 2017 | -27.71M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.559M |
| June 30, 2017 | -7.465M |
| March 31, 2017 | -6.266M |
| December 31, 2016 | -7.326M |
| September 30, 2016 | -23.92M |
| June 30, 2016 | -8.652M |
| March 31, 2016 | 222.44M |
| December 31, 2015 | 2.633M |
| September 30, 2015 | -4.19M |
| June 30, 2015 | -6.431M |
| March 31, 2015 | -4.634M |
| December 31, 2014 | -13.78M |
| September 30, 2014 | -1.342M |
| June 30, 2014 | -0.057M |
| March 31, 2014 | -11.21M |
| December 31, 2013 | -17.53M |
| September 30, 2013 | -14.58M |
| June 30, 2013 | -6.819M |
| March 31, 2013 | 7.634M |
| December 31, 2012 | -20.94M |
| September 30, 2012 | -0.633M |
| June 30, 2012 | -22.89M |
| March 31, 2012 | 55.82M |
| December 31, 2011 | -30.84M |
| September 30, 2011 | -15.10M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-58.77M
Minimum
Dec 2023
159.12M
Maximum
Jun 2022
-6.164M
Average
-19.79M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Inspire Medical Systems Inc | -10.12M |
| SI-BONE Inc | 0.842M |
| Inari Medical Inc | -2.41M |
| Electromed Inc | 0.026M |
| Myomo Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 56.40M |
| Cash from Investing (Quarterly) | -4.855M |
| Free Cash Flow | 106.32M |
| Free Cash Flow Per Share (Quarterly) | 1.636 |
| Free Cash Flow to Equity (Quarterly) | 90.48M |
| Free Cash Flow to Firm (Quarterly) | 59.27M |
| Free Cash Flow Yield | 5.44% |